Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | MMP3 | P08254 | 2/20 | 0.42 |
| ▸ | MMP13 | P45452 | 2/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 7/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | FPR1 | P21462 | 2/20 | 0.36 |
| ▸ | FPR2 | P25090 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4879976 | 1.00 | MMP1 (0.42) | MMP1MMP2MMP3MMP13SOAT1 | |
| SCHEMBL4871938 | 0.92 | MMP1 (0.42) | MMP1MMP2MMP3MMP13SOAT1 | |
| SCHEMBL4878196 | 0.92 | MMP1 (0.42) | MMP1MMP2MMP3MMP13SOAT1 | |
| SCHEMBL4871944 | 0.92 | MMP1 (0.42) | MMP1MMP2MMP3MMP13SOAT1 | |
| SCHEMBL4872172 | 0.91 | MMP1 (0.42) | MMP1MMP2MMP3MMP13SOAT1 | |
| SCHEMBL4872167 | 0.91 | MMP1 (0.42) | MMP1MMP2MMP3MMP13SOAT1 | |
| SCHEMBL14194853 | 0.88 | ALDH1A1 (0.42) | MMP1MMP2MMP3MMP13SOAT1 | |
| SCHEMBL14194849 | 0.88 | CA12 (0.46) | MMP1MMP2MMP3MMP13SOAT1 | |
| Hydrochloric Acid SCHEMBL4878392 | 0.87 | MEN1 (0.43) | MMP1MMP2MMP3MMP13SOAT1 | |
| Hydrochloric Acid SCHEMBL4878397 | 0.87 | MEN1 (0.43) | MMP1MMP2MMP3MMP13SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080096922-A1 | Novel Sulfonamide derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
| EP-1736467-A1 | NOVEL SULFONAMIDE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2006-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096922-A1 | Novel Sulfonamide derivative | NR4A1, NR4A2, NR4A3 | MMP1 3963/4885MMP2 3066/4885MMP3 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.